An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease

NCT00091845 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

50

Enrollment

INDUSTRY

Sponsor class

Stopped Due to limited pool of eligble WNV patients

Conditions

West Nile Fever

Interventions

DRUG: AVI-4020 Injection

Sponsor

Sarepta Therapeutics, Inc.